Households suffering with 2 symptoms urged to wash bedding immediately
Hayfever season is here, and around 16 million Brits suffer with its pesky symptoms every year as the pollen count increases.
Pollen can get onto anything and everything, including slotting itself into the fibres of our clothes - and our bedding. This is why hayfever sufferers, especially those enduring constant sneezing, itchy eyes and general irritation, should ensure theirs is washed immediately.
Not only that, washing your bedding is crucial for maintaining hygiene. Unwashed bedsheets can accumulate a lot of bacteria, including microscopic organisms like dust mites and other allergens that can trigger allergies, skin problems and asthma. These allergens thrive in most environments, which is why it's even more important to wash your bedding during the warmer months when humidity increases. This includes sheets, pillowcases, and blankets.
According to clearing expert Joyce French at HomeHow.co.uk, he explained: 'Regularly washing bedding is always an important task, but particularly so during hay fever season to keep symptoms at bay and allow for restful sleep. Wash your sheets, duvet covers, and pillowcases in a hot wash once a week – hot water is crucial for killing dust mites and eliminating allergens.'
Generally, it's recommended to change bed sheets at least once a week. However, in some cases, it can be extended to two weeks when it's considered acceptable. For example, if you don't sweat excessively or have any pets that sleep in the bed. If you're prone to allergies, it's better to be on the side of caution and wash your bedding more frequently - better be safe than sorry!
Choosing the right fabrics for your bedding - as well as your nightwear - plays a significant role in improving your sleep quality when dealing with allergies. On the other hand, synthetic fabrics, like polyester, tend to trap moisture and heat, which creates the ideal environment for dust mines.
As explained by Secret Linen, natural fibres such as cotton, linen, and bamboo are much more breathable, allowing air to flow and becoming 'less hospitable' to dust mites. Moreover, these materials help regulate body temperature, avoiding sweat buildup and keeping your skin comfortable throughout the night, ensuring a good sleep.
By changing your bedsheets regularly - as well as your pyjamas - you can rest assured of having a good night's sleep, away from any allergies that these can bring. Now that spring time has arrived, and summer is around the corner, it's important to avoid these at all costs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
2 hours ago
- Daily Mirror
Huge rise in Brits catching deadly organ-destroying virus on holiday
Chikungunya cases are at a record high in England after tripling in just a year with the majority reported travelling from Sri Lanka, India and Mauritius Cases of a deadly virus caught by Brits while abroad have tripled in the last year hitting record levels, government data shows. The latest UK Health Security Agency figures show an increase in travel-associated chikungunya cases in England. A total of 73 cases were reported between January and June 2025. The same period in 2024 saw just 27 cases. This is the highest number of cases ever recorded in England. The report which covers cases in England, Wales and Northern Ireland, reveals that there were also three cases of Oropouche virus in travellers arriving back in the UK. It was the first time Oropouche has been recorded here and all cases were associated with travel from Brazil. It comes after a pilot says he's found the location of Amelia Earhart's aircraft using Google Earth. Chikungunya is a mosquito-borne infection related to overseas travel, with symptoms including a sudden onset of fever usually accompanied by joint pain. Most people recover fully within two weeks, but joint pain can persist for months or even years. Up to 12% of patients still experiencing discomfort three years later. Serious complications are uncommon, but the disease can be fatal in very rare cases, especially if caught by the very young, old or those with other underlying illnesses. Of the 73 chikungunya cases, the majority reported travel to Sri Lanka, India and Mauritius, linked with ongoing local outbreaks in countries in the Indian Ocean region. All cases were reported in England, with the majority in London. There are only two species of mosquito that transmit the disease and they are not established in the UK. This is because our climate is generally not suitable for their survival and breeding. There is currently no risk of onward transmission of chikungunya in the UK, the UKHSA says. There are two vaccines recently been approved for use in the UK based on The Joint Committee on Vaccination and Immunisation(JCVI), to protect against chikungunya. Dr Philip Veal, Consultant in Public Health at UKHSA, said: "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. "Thankfully symptoms usually improve within a few weeks, but joint pain may last for months or longer. It is essential to take precautions against mosquito bites when travelling. Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk. "Before you travel, check the Travel Health Pro Website for the latest advice on your destination. A chikungunya vaccine may also be considered for those travelling to higher-risk regions." Oropouche virus is spread predominantly by midge bites rather than mosquito bites. The primary type of midge responsible for the outbreak in the Americas is not seen in the UK and Europe. If a person becomes unwell with symptoms such as high fever, chills, headache, joint pain and muscle aches following travel to affected areas, they should seek urgent medical advice. There has been a rise in Oropouche virus infections globally since 2024, especially in multiple countries in South America, Central America and the Caribbean, with Brazil reporting the largest outbreaks. Due to the increase in cases, and some recent concerns regarding Oropouche virus infection during pregnancy, pregnant travellers should take particular care. The report also noted a significant increase in travel-associated cholera cases in the UK, with eight cases (compared to just one case in 2024) – most cases reported travel history to India and Ethiopia – with all Ethiopia-linked cases associated with an outbreak there. There were 161 dengue cases reported in England, Wales and Northern Ireland, a 67% decrease compared to the same period in 2024, which saw 490 cases Zika virus disease cases also decreased to four cases in the first half of 2025, down from 9 cases in 2024.
Scottish Sun
2 hours ago
- Scottish Sun
‘King Kong' of fat jabs could DOUBLE in price – soaring to over £300 for the max doses
More than a million people are thought to be taking Mounjaro FAT JAB BLOW 'King Kong' of fat jabs could DOUBLE in price – soaring to over £300 for the max doses Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) MOUNJARO prices in the UK could double as the manufacturer will next month hike the rate it charges pharmacies for the fat jab. US-based Eli Lilly said it is increasing charges for the blockbuster weight loss injection in Britain to 'address inconsistencies' with what it commands from other rich countries. Sign up for Scottish Sun newsletter Sign up 1 Mounjaro is by far the UK's most popular weight loss drug Credit: Alamy A middle-sized 5mg dose will nearly double from £92 to £180 from September 1. The maximum available dose, 15mg, will rise from £122 to £330. Lilly said it has struck a secret, cheaper deal with the NHS to ensure availability for the patients most in need. It also claimed to have negotiated with big private suppliers to ensure the whole increase is not passed on to patients. 'At launch, Lilly agreed to a UK list price that is significantly below the European average More than a million Brits are thought to be taking the weight loss injection privately and now face an increase in their monthly bill. Ministers are keen to use the drug to tackle the UK's bulging waistline and roll it out to millions more people over the next decade. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. 'We have reached an agreement with the NHS to ensure continued supply and patient access. 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. 'The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability. 'With changes in the environment and new clinical evidence supporting the value of Mounjaro, we are now aligning the list price more consistently to ensure fair global contributions to the cost of innovation.'
Daily Mirror
8 hours ago
- Daily Mirror
Find out your risk of heart disease 10 years early with online tool
According to the British Heart Foundation, around 7.6 million Brits are thought to be living with cardiovascular disease. A new online tool could predict your risk of heart disease by up to 10 years early. The calculator can determine a person's heart age and work out their cardiovascular disease risk. Heart health is a huge issue across the UK. According to the British Heart Foundation (BHF), around 7.6 million Brits are thought to be living with cardiovascular disease. This includes conditions like coronary heart disease, stroke, and heart failure. Cardiovascular disease is also a major contributor to fatalities in the UK, accounting for one in four premature deaths in the UK. The same is true worldwide, with the disease linked to around a quarter of all deaths. Now, researchers from the Northwestern University Feinberg School of Medicine in Chicago have created a simple way to help people understand more about their potential risk. This involved gathering information needed to calculate a person's 'heart age'. This is not necessarily the same as their chronological age. People with issues such as high blood pressure, type 2 diabetes, and obesity are more likely to have a higher heart age, for example. Sadiya Khan, the Magerstadt Professor of Cardiovascular Epidemiology and the study's senior author, said: 'We hope this tool helps doctors and patients discuss risk for heart disease more effectively so we can better inform what therapies can prevent heart attacks, stroke, or heart failure events from ever happening.' After creating the calculator, the team trialled it on more than 14,000 US adults between the ages of 30 to 79, who had participated in the National Health and Nutrition Examination Survey between 2011 and 2020. At the time of the survey they did not have a cardiovascular disease diagnosis. But following analysis, researchers found that on average, women had a heart age of 55.4 and a chronological age of 51.3, while men had a heart age of 56.7 and a chronological age of 49.7. Prof Khan continued: 'Many people who should be on medicine to lower their risk for heart attack, stroke or heart failure are not on these medications. We hope this new heart age calculator will help support discussions about prevention and ultimately improve health for all people. 'The important thing is that we have very good options available in our toolbox to help slow that aging down if we can identify it. This may be even more important in younger people who don't often think about their risk for heart disease.' To calculate your heart age use the online tool here. If you are concerned about your heart health, you should speak to your GP.
